Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Eli Lilly’s Loxo Oncology Enters into $1.6 Billion Research and Collaboration Agreement with Merus N.V.
Eli Lilly’s Loxo Oncology Enters into $1.6 Billion Research and Collaboration Agreement with Merus N.V.
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Merus N.
Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.
Servier and MiNA Partner to Create Entirely New Class of Drugs
Servier and MiNA Partner to Create Entirely New Class of Drugs
France-based Servier and U.
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
MARLBOROUGH, Mass.
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
KENILWORTH, NJ, USA I January 20, 2021 I Merck (NYSE.
FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone) for Unclassifiable Interstitial Lung Disease
FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone) for Unclassifiable Interstitial Lung Disease
SOUTH SAN FRANCISCO, CA, USA, January 21, 2021.
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A drug developed by Eli Lilly and Company dramatically reduced the risk of developing symptomatic COVID-19 among nursing home residents, the company found.
Mark Cuban launches low-cost generic drug company
Mark Cuban launches low-cost generic drug company
Billionaire Mark Cuban launched a drug company this week that is “dedicated to producing low-cost versions of high-cost generic drugs” and pledges “radical transparency” in pricing.
Doptelet® (avatrombopag) approved in the EU for treatment of ITP
Doptelet® (avatrombopag) approved in the EU for treatment of ITP
STOCKHOLM, Sweden I January 20, 2021 ISwedish Orphan Biovitrum AB (publ) (Sobi™) (STO.
Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson's disease
Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson's disease
NEW YORK, Jan.
Japan to use data from outside clinical trials in drug approvals
Japan to use data from outside clinical trials in drug approvals
TOKYO -- Japan's health ministry will issue new guidelines next fiscal year aimed at helping new drugs get to market faster, by allowing pharmaceutical companies to use data from outside of clinic...
Research establishes antibiotic potential for cannabis molecule
Research establishes antibiotic potential for cannabis molecule
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand